Several systemic diseases, including Addisons disease, PeutzJeghers syndrome, McCuneAlbright syndrome, Cowden syndrome, neurofibromatosis, acquired immunodeficiency syndrome, haemochromatosis, and hyperthyroidism, as well as uncommon conditions such as Nelsons syndrome, polyostotic fibrous dysplasia syndrome, LaugierHunziker syndrome, and the Carney complex, may feature oral melanotic macules [1, 26, 27]
A personalized approach ensures optimal therapeutic outcomes while minimizing potential adverse effects and maximizing adherence
Clinical-stage obesity-related drugs targeting GLP-1R, GIPR, or GDF-8 through November 2024
Eli Lilly has likewise announced multibillion-dollar projects targeting GLP-1 production
Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence
GLP-1 medications slow gastric emptying and reduce appetite, which may intensify these digestive symptoms if not managed thoughtfully